About Metalytics, Inc.
Metalytics provides critical information about cellular metabolic rates in living cells, in vitro and in vivo, giving actionable results which can be implemented to accelerate research, development, and manufacturing timelines. Our CoreMFA Big Data platform allows investigators to quickly and rationally engineer improved cells and/or optimize cell culture media components with applications in a diversity of industries, including biopharma and specialty chemical manufacturing, biofuels and bioproducts production, synthetic biology, agricultural biotechnology, and cell-based protein and food production. By highlighting the most promising engineering targets in metabolism, reduced time-to-market, increased production quantity and quality, lower capital requirements, and reduced raw material costs can be achieved.
Jamey Young, PhD
Founder and Chief Scientific Officer
Jamey is the Founder and Chief Scientific Officer at Metalytics and a Professor in both the Chemical & Biomolecular Engineering and Molecular Physiology & Biophysics Departments at Vanderbilt University in Nashville, TN. He received his PhD in Chemical Engineering at Purdue University and was a post-doctoral fellow at MIT. His current research applies metabolic engineering in combination with current biochemical and molecular biology approaches to investigate a variety of cell models of relevance to medicine and biotechnology. Jamey developed the proprietary flux analysis software, INCA (the core technology of Metalytics) and his innovative research has been recognized with various awards, including an NSF CAREER Award and a DOE Early Career Award.
Eric Cumming, MBA
Chief Executive Officer
Eric is the Chief Executive Officer at Metalytics. He has over 25 years of executive, entrepreneurial, and business strategy experience in technology, health and biotechnology, building systems, energy, and venture funding. Eric’s roles have also included product conceptualization and development, technology architecture, as well as product management and investment fundraising. Eric earned his MBA from the University of Michigan and his BSc from Oakland University.
Sam Yenne, PhD, MBA
Chief Operating Officer
Sam is the Chief Operating Officer at Metalytics. Sam has over 25 years of corporate leadership along with product discovery and development expertise in the life sciences and related industries. Dr. Yenne has held positions of Project Manager and VP of Development in four different biotechnology companies where he was responsible for developing products from inception to market launch. Prior to this Sam was a strategic business consultant, a project manager for an international chemical and life sciences company, and a scientist conducting complex biological experiments to determine the fate of xenobiotic compounds. Sam earned his MBA from Duke University, his PhD from Virginia Tech, and his BS and MS degrees from the University of Idaho.
Mark Lombard, MBA
Vice President, Business Development
Mark is the Vice President of Business Development at Metalytics. Over the course of his 25 years in life sciences, Mark has held leadership positions in the public and private sectors, both as a scientist and business manager. He has worked as a molecular biologist with several large-cap biopharma companies, as a business and economic developer focused on life science business recruitment and expansion, and as a consultant to domestic and international biopharma companies and contract research organizations. Mark received a BS in biology and an MS in cell & molecular biology from Western Michigan University, and an MBA from North Carolina State University.